APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal OTC Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchGastrointestinal OTC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal OTC Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal OTC Drugs include Boehringer Ingelheim, Perrigo, Procter & Gamble, Purdue Pharma, Reckitt Benckiser, Bayer, GlaxoSmithKline, Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastrointestinal OTC Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastrointestinal OTC Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastrointestinal OTC Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastrointestinal OTC Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastrointestinal OTC Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastrointestinal OTC Drugs Market by Company

Boehringer Ingelheim

Perrigo

Procter & Gamble

Purdue Pharma

Reckitt Benckiser

Bayer

GlaxoSmithKline

Pfizer

Johnson & Johnson

Nestle

Sanofi

Teva Pharmaceutical

Abbott

Gastrointestinal OTC Drugs Segment by Type

Anti-Emetics

Laxatives

Anti-Flatulents

Anti-Diarrheals

PPIs

H2-Antaginists

Other

Gastrointestinal OTC Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Gastrointestinal OTC Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal OTC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal OTC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal OTC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastrointestinal OTC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anti-Emetics Table 2. Major Company of Laxatives Table 3. Major Company of Anti-Flatulents Table 4. Major Company of Anti-Diarrheals Table 5. Major Company of PPIs Table 6. Major Company of H2-Antaginists Table 7. Major Company of Other Table 8. Global Gastrointestinal OTC Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 10. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global Gastrointestinal OTC Drugs Price by Type (2021-2026) & (US$/Unit) Table 14. Global Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 15. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global Gastrointestinal OTC Drugs Price by Type (2027-2032) & (US$/Unit) Table 19. North America Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 20. North America Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 22. Europe Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 26. Latin America Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. Gastrointestinal OTC Drugs Industry Trends Table 30. Gastrointestinal OTC Drugs Industry Drivers Table 31. Gastrointestinal OTC Drugs Industry Opportunities and Challenges Table 32. Gastrointestinal OTC Drugs Industry Restraints Table 33. Global Gastrointestinal OTC Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Gastrointestinal OTC Drugs Revenue Market Share by Company (2021-2026) Table 35. Global Gastrointestinal OTC Drugs Sales by Company (2021-2026) & (K Units) Table 36. Global Gastrointestinal OTC Drugs Sales Share by Company (2021-2026) Table 37. Global Gastrointestinal OTC Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Gastrointestinal OTC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Gastrointestinal OTC Drugs Major Company Production Sites and Headquarters Table 40. Global Gastrointestinal OTC Drugs Company, Product Type & Application Table 41. Global Gastrointestinal OTC Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Gastrointestinal OTC Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Gastrointestinal OTC Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global Gastrointestinal OTC Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Gastrointestinal OTC Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global Gastrointestinal OTC Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 62. Global Gastrointestinal OTC Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global Gastrointestinal OTC Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global Gastrointestinal OTC Drugs Price by Application (2027-2032) & (US$/Unit) Table 66. North America Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 67. North America Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 69. Europe Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 73. Latin America Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Perrigo Company Information Table 82. Perrigo Business Overview Table 83. Perrigo Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Perrigo Gastrointestinal OTC Drugs Product Portfolio Table 85. Perrigo Recent Development Table 86. Procter & Gamble Company Information Table 87. Procter & Gamble Business Overview Table 88. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio Table 90. Procter & Gamble Recent Development Table 91. Purdue Pharma Company Information Table 92. Purdue Pharma Business Overview Table 93. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio Table 95. Purdue Pharma Recent Development Table 96. Reckitt Benckiser Company Information Table 97. Reckitt Benckiser Business Overview Table 98. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio Table 100. Reckitt Benckiser Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bayer Gastrointestinal OTC Drugs Product Portfolio Table 105. Bayer Recent Development Table 106. GlaxoSmithKline Company Information Table 107. GlaxoSmithKline Business Overview Table 108. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio Table 110. GlaxoSmithKline Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer Gastrointestinal OTC Drugs Product Portfolio Table 115. Pfizer Recent Development Table 116. Johnson & Johnson Company Information Table 117. Johnson & Johnson Business Overview Table 118. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio Table 120. Johnson & Johnson Recent Development Table 121. Nestle Company Information Table 122. Nestle Business Overview Table 123. Nestle Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Nestle Gastrointestinal OTC Drugs Product Portfolio Table 125. Nestle Recent Development Table 126. Sanofi Company Information Table 127. Sanofi Business Overview Table 128. Sanofi Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sanofi Gastrointestinal OTC Drugs Product Portfolio Table 130. Sanofi Recent Development Table 131. Teva Pharmaceutical Company Information Table 132. Teva Pharmaceutical Business Overview Table 133. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio Table 135. Teva Pharmaceutical Recent Development Table 136. Abbott Company Information Table 137. Abbott Business Overview Table 138. Abbott Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Abbott Gastrointestinal OTC Drugs Product Portfolio Table 140. Abbott Recent Development Table 141. North America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 143. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 144. North America Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Gastrointestinal OTC Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. North America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Gastrointestinal OTC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Gastrointestinal OTC Drugs Market Share by Country (2021-2026) Table 149. North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Gastrointestinal OTC Drugs Market Share Forecast by Country (2027-2032) Table 151. Europe Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 153. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 154. Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Gastrointestinal OTC Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Gastrointestinal OTC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Gastrointestinal OTC Drugs Market Share by Country (2021-2026) Table 159. Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Gastrointestinal OTC Drugs Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Gastrointestinal OTC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Gastrointestinal OTC Drugs Market Share by Country (2021-2026) Table 169. Asia-Pacific Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Gastrointestinal OTC Drugs Market Share Forecast by Country (2027-2032) Table 171. Latin America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 173. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 174. Latin America Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Gastrointestinal OTC Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Gastrointestinal OTC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Gastrointestinal OTC Drugs Market Share by Country (2021-2026) Table 179. Latin America Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Gastrointestinal OTC Drugs Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Country (2021-2026) Table 189. Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Gastrointestinal OTC Drugs Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Gastrointestinal OTC Drugs Distributors List Table 194. Gastrointestinal OTC Drugs Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Gastrointestinal OTC Drugs Image Figure 2. Global Gastrointestinal OTC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal OTC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal OTC Drugs Sales (2021-2032) & (K Units) Figure 5. Anti-Emetics Image Figure 6. Global Anti-Emetics Sales YoY Growth (2021-2032) & (K Units) Figure 7. Laxatives Image Figure 8. Global Laxatives Sales YoY Growth (2021-2032) & (K Units) Figure 9. Anti-Flatulents Image Figure 10. Global Anti-Flatulents Sales YoY Growth (2021-2032) & (K Units) Figure 11. Anti-Diarrheals Image Figure 12. Global Anti-Diarrheals Sales YoY Growth (2021-2032) & (K Units) Figure 13. PPIs Image Figure 14. Global PPIs Sales YoY Growth (2021-2032) & (K Units) Figure 15. H2-Antaginists Image Figure 16. Global H2-Antaginists Sales YoY Growth (2021-2032) & (K Units) Figure 17. Other Image Figure 18. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Gastrointestinal OTC Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Gastrointestinal OTC Drugs Market Share by Type 2025 VS 2032 Figure 21. North America Gastrointestinal OTC Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America Gastrointestinal OTC Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe Gastrointestinal OTC Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe Gastrointestinal OTC Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America Gastrointestinal OTC Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Gastrointestinal OTC Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Gastrointestinal OTC Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Online Pharmacies Image Figure 36. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 37. Hospital Pharmacies Image Figure 38. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Gastrointestinal OTC Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Gastrointestinal OTC Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Gastrointestinal OTC Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Gastrointestinal OTC Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Gastrointestinal OTC Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Gastrointestinal OTC Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Gastrointestinal OTC Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Gastrointestinal OTC Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Gastrointestinal OTC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Gastrointestinal OTC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Gastrointestinal OTC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Gastrointestinal OTC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Gastrointestinal OTC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Gastrointestinal OTC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Gastrointestinal OTC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Gastrointestinal OTC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Gastrointestinal OTC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Gastrointestinal OTC Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Gastrointestinal OTC Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Emetics
  • Laxatives
  • Anti-Flatulents
  • Anti-Diarrheals
  • PPIs
  • H2-Antaginists
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Perrigo
  • Procter & Gamble
  • Purdue Pharma
  • Reckitt Benckiser
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Nestle
  • Sanofi
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastrointestinal OTC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastrointestinal OTC Drugs Market by Type
  6. 1.3.1 Anti-Emetics
  7. 1.3.2 Laxatives
  8. 1.3.3 Anti-Flatulents
  9. 1.3.4 Anti-Diarrheals
  10. 1.3.5 PPIs
  11. 1.3.6 H2-Antaginists
  12. 1.3.7 Other
  13. 1.4 Global Gastrointestinal OTC Drugs Market Size by Type
  14. 1.4.1 Global Gastrointestinal OTC Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Gastrointestinal OTC Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastrointestinal OTC Drugs Industry Trends
  2. 2.2 Gastrointestinal OTC Drugs Industry Drivers
  3. 2.3 Gastrointestinal OTC Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal OTC Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastrointestinal OTC Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastrointestinal OTC Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Gastrointestinal OTC Drugs Price (2021-2026)
  4. 3.4 Global Gastrointestinal OTC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal OTC Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Gastrointestinal OTC Drugs Company, Product Type & Application
  7. 3.7 Global Gastrointestinal OTC Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal OTC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal OTC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal OTC Drugs Tier 1, Tier 2, and Tier 3
4 Gastrointestinal OTC Drugs Regional Status and Outlook
  1. 4.1 Global Gastrointestinal OTC Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastrointestinal OTC Drugs Historic Market Size by Region
  3. 4.2.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastrointestinal OTC Drugs by Application
  1. 5.1 Gastrointestinal OTC Drugs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Gastrointestinal OTC Drugs Market Size by Application
  6. 5.2.1 Global Gastrointestinal OTC Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gastrointestinal OTC Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Perrigo
  8. 6.2.1 Perrigo Company Information
  9. 6.2.2 Perrigo Business Overview
  10. 6.2.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
  12. 6.2.5 Perrigo Recent Developments
  13. 6.3 Procter & Gamble
  14. 6.3.1 Procter & Gamble Company Information
  15. 6.3.2 Procter & Gamble Business Overview
  16. 6.3.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
  18. 6.3.5 Procter & Gamble Recent Developments
  19. 6.4 Purdue Pharma
  20. 6.4.1 Purdue Pharma Company Information
  21. 6.4.2 Purdue Pharma Business Overview
  22. 6.4.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
  24. 6.4.5 Purdue Pharma Recent Developments
  25. 6.5 Reckitt Benckiser
  26. 6.5.1 Reckitt Benckiser Company Information
  27. 6.5.2 Reckitt Benckiser Business Overview
  28. 6.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
  30. 6.5.5 Reckitt Benckiser Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Nestle
  56. 6.10.1 Nestle Company Information
  57. 6.10.2 Nestle Business Overview
  58. 6.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
  60. 6.10.5 Nestle Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Teva Pharmaceutical
  68. 6.12.1 Teva Pharmaceutical Company Information
  69. 6.12.2 Teva Pharmaceutical Business Overview
  70. 6.12.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
  72. 6.12.5 Teva Pharmaceutical Recent Developments
  73. 6.13 Abbott
  74. 6.13.1 Abbott Company Information
  75. 6.13.2 Abbott Business Overview
  76. 6.13.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
  78. 6.13.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Gastrointestinal OTC Drugs Sales by Country
  2. 7.1.1 North America Gastrointestinal OTC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastrointestinal OTC Drugs Market Size by Country
  6. 7.2.1 North America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastrointestinal OTC Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastrointestinal OTC Drugs Sales by Country
  2. 8.1.1 Europe Gastrointestinal OTC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastrointestinal OTC Drugs Market Size by Country
  6. 8.2.1 Europe Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastrointestinal OTC Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastrointestinal OTC Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastrointestinal OTC Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastrointestinal OTC Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastrointestinal OTC Drugs Sales by Country
  2. 10.1.1 South America Gastrointestinal OTC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastrointestinal OTC Drugs Market Size by Country
  6. 10.2.1 South America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastrointestinal OTC Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastrointestinal OTC Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastrointestinal OTC Drugs Value Chain Analysis
  2. 12.1.1 Gastrointestinal OTC Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastrointestinal OTC Drugs Production Mode & Process
  7. 12.2 Gastrointestinal OTC Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastrointestinal OTC Drugs Distributors
  10. 12.2.3 Gastrointestinal OTC Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst